Report Detail
Global (United States, European Union and China) Biologic Drugs Market Research Report 2019-2025
- RnM3460360 |
- 27 May, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Biologic Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologic Drugs.
This report studies the global market size of Biologic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biologic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Market Segment by Product Type
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Market Segment by Application
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biologic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biologic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biologic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Biologic Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Humira
- 1.3.3 Remicade
- 1.3.4 Rituxan
- 1.3.5 Enbrel
- 1.3.6 Lantus
- 1.3.7 Avastin
- 1.3.8 Herceptin
- 1.3.9 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Biologic Drugs Market Share by Application (2019-2025)
- 1.4.2 Diabetes
- 1.4.3 Inflammation
- 1.4.4 Auto-Immune Diseases
- 1.4.5 Blood Diseases
- 1.4.6 Cardiovascular Diseases
- 1.4.7 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Biologic Drugs Market Size
- 2.1.1 Global Biologic Drugs Revenue 2014-2025
- 2.1.2 Global Biologic Drugs Sales 2014-2025
- 2.2 Biologic Drugs Growth Rate by Regions
- 2.2.1 Global Biologic Drugs Sales by Regions 2014-2019
- 2.2.2 Global Biologic Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Biologic Drugs Sales by Manufacturers
- 3.1.1 Biologic Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Biologic Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Biologic Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Biologic Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Biologic Drugs Price by Manufacturers
- 3.4 Key Manufacturers Biologic Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Biologic Drugs Market
- 3.6 Key Manufacturers Biologic Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Humira Sales and Revenue (2014-2019)
- 4.1.2 Remicade Sales and Revenue (2014-2019)
- 4.1.3 Rituxan Sales and Revenue (2014-2019)
- 4.1.4 Enbrel Sales and Revenue (2014-2019)
- 4.1.5 Lantus Sales and Revenue (2014-2019)
- 4.1.6 Avastin Sales and Revenue (2014-2019)
- 4.1.7 Herceptin Sales and Revenue (2014-2019)
- 4.1.8 Others Sales and Revenue (2014-2019)
- 4.2 Global Biologic Drugs Sales Market Share by Type
- 4.3 Global Biologic Drugs Revenue Market Share by Type
- 4.4 Biologic Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Biologic Drugs Sales by Application
6 United States
- 6.1 United States Biologic Drugs Breakdown Data by Company
- 6.2 United States Biologic Drugs Breakdown Data by Type
- 6.3 United States Biologic Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Biologic Drugs Breakdown Data by Company
- 7.2 European Union Biologic Drugs Breakdown Data by Type
- 7.3 European Union Biologic Drugs Breakdown Data by Application
8 China
- 8.1 China Biologic Drugs Breakdown Data by Company
- 8.2 China Biologic Drugs Breakdown Data by Type
- 8.3 China Biologic Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Biologic Drugs Breakdown Data by Company
- 9.2 Rest of World Biologic Drugs Breakdown Data by Type
- 9.3 Rest of World Biologic Drugs Breakdown Data by Application
- 9.4 Rest of World Biologic Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Biologic Drugs Sales by Countries
- 9.4.2 Rest of World Biologic Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roche
- 10.1.1 Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.1.4 Biologic Drugs Product Introduction
- 10.1.5 Roche Recent Development
- 10.2 Abbott Laboratories
- 10.2.1 Abbott Laboratories Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.2.4 Biologic Drugs Product Introduction
- 10.2.5 Abbott Laboratories Recent Development
- 10.3 Johnson & Johnson
- 10.3.1 Johnson & Johnson Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.3.4 Biologic Drugs Product Introduction
- 10.3.5 Johnson & Johnson Recent Development
- 10.4 Merck & Co.
- 10.4.1 Merck & Co. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.4.4 Biologic Drugs Product Introduction
- 10.4.5 Merck & Co. Recent Development
- 10.5 Pfizer
- 10.5.1 Pfizer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.5.4 Biologic Drugs Product Introduction
- 10.5.5 Pfizer Recent Development
- 10.6 Amgen
- 10.6.1 Amgen Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.6.4 Biologic Drugs Product Introduction
- 10.6.5 Amgen Recent Development
- 10.7 Sanofi
- 10.7.1 Sanofi Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.7.4 Biologic Drugs Product Introduction
- 10.7.5 Sanofi Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.8.4 Biologic Drugs Product Introduction
- 10.8.5 Novartis Recent Development
- 10.9 Eli Lilly
- 10.9.1 Eli Lilly Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.9.4 Biologic Drugs Product Introduction
- 10.9.5 Eli Lilly Recent Development
- 10.10 Amgen
- 10.10.1 Amgen Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Biologic Drugs
- 10.10.4 Biologic Drugs Product Introduction
- 10.10.5 Amgen Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Biologic Drugs Sales Channels
- 11.2.2 Biologic Drugs Distributors
- 11.3 Biologic Drugs Customers
12 Market Forecast
- 12.1 Global Biologic Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Biologic Drugs Sales Forecast by Type
- 12.3 Global Biologic Drugs Sales Forecast by Application
- 12.4 Biologic Drugs Forecast by Regions
- 12.4.1 Global Biologic Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Biologic Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Biologic Drugs . Industry analysis & Market Report on Biologic Drugs is a syndicated market report, published as Global (United States, European Union and China) Biologic Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biologic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
